Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer... by Klara Kvorning Ternov, Jens Sønksen, Mikkel Fode, Henriette Lindberg, Caroline Michaela Kistorp, Rasmus Bisbjerg, Ganesh Palapattu, Peter Busch Østergren

Get full text